PlainPharmaWatch

CMS Open Payments · Program Year 2024

Legend Biotech USA Inc.

Legend Biotech USA Inc. reported $189,172.68 in payments to 1,318 physicians and teaching hospitals across 1,318 transactions.

See the rankings → How this is sourced
$189.2K
Total payments
1,318
Transactions
1,318
Recipients
+$44.5K
General Payments vs PY2023

Legend Biotech USA Inc. reported $189,172.68 in payments to 1,318 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #1018 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $143.53 per recipient across 4 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Legend Biotech USA Inc. pairs below-median payment volume with an unusually diversified payment pattern across a wide recipient base.

#1018
of 1,925 companies
0.0%
of all US industry payments
0.1%
paid to its single top recipient
4
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Legend Biotech USA Inc.'s CMS-reported General Payments increased by $44.5K (+30.8%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: LEGEND BIOTECH USA INC.PY2023: LEGEND BIOTECH USA INC.PY2024: Legend Biotech USA Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$144.7KPY2024$189.2K
PY2023
$144,674.70
PY2024
$189,172.68

How Legend Biotech USA Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Legend Biotech USA Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$189,173 47th percentile higher than 47% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). This entry sits in this band. $242,294–$752,621: 270 reporting companies (14%). Above this entry. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Legend Biotech USA Inc.

Averaging $143.53 per transaction and $143.53 per recipient, Legend Biotech USA Inc.'s Program Year 2024 total comes to $189,172.68 across 1,318 transactions and 1,318 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #1018 of 1,925 companies, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

45 transactions worth $136.7K make "Consulting Fee" the top general-payment category in the 4-category breakdown below, 72.3% of the reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

"Consulting Fee" leads Legend Biotech USA Inc.'s 4-category general-payment breakdown at $136.7K, 72.3% of the reported total.

How Legend Biotech USA Inc. divides its payments

General-payment categories, ordered by reported total

1. Consulting Fee$136.7K2. Food and Beverage$41.0K3. Travel and Lodging$10.6K4. Education$874.48
Payment Type Amount Transactions
Consulting Fee $136.7K 45
Food and Beverage $41.0K 1,161
Travel and Lodging $10.6K 78
Education $874.48 34

Recipient Concentration in General Payments

The five largest recipient relationships account for $54,446.95 (28.8%) of $189,172.68 in this company's General Payments records across 970 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Legend Biotech USA Inc.

The five named recipients with the highest reported General Payments from this company

Binod Dhakal$16.4KAmer Beitinjaneh$11.1KMurali Janakiram$9.6KJeremy Pantin$8.7KMelissa Alsina$8.6K
  1. 1

    Binod Dhakal

    $16,413.80 across 13 reported transactions

  2. 2

    Amer Beitinjaneh

    $11,050.72 across 7 reported transactions

  3. 3

    Murali Janakiram

    $9,641.77 across 12 reported transactions

  4. 4

    Jeremy Pantin

    $8,708.66 across 6 reported transactions

  5. 5

    Melissa Alsina

    $8,632.00 across 5 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $143.53. Average per recipient: $143.53.

Total Amount

$189,172.68

Avg per Transaction

$143.53

Avg per Recipient

$143.53

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Legend Biotech USA Inc. Share

0.0%

#1018 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Legend Biotech USA Inc.

AppliedVR Inc

$189.1K 85 recipients

VOCO America Inc.

$189.4K 2,470 recipients

Kirwan Surgical Products LLC

$189.8K 4 recipients

Maquet Cardiovascular L.L.C.

$188.3K 167 recipients

Kulzer, LLC

$187.8K 1,403 recipients

Sealonix Inc.

$186.9K 19 recipients

Frequently Asked Questions

How much did Legend Biotech USA Inc. pay to physicians and hospitals in 2024? ▾
0.0% of all industry payments reported to CMS Open Payments for 2024 came from Legend Biotech USA Inc., totaling $189,172.68 across 1,318 transactions to physicians and hospitals.
How many physicians received payments from Legend Biotech USA Inc.? ▾
1,318 physicians and teaching hospitals received payments from Legend Biotech USA Inc. in 2024, averaging $143.53 per recipient.
What types of payments did Legend Biotech USA Inc. make? ▾
Legend Biotech USA Inc. made 4 different types of general payments (consulting, meals, travel, and similar categories). The largest general-payment category was "Consulting Fee" at $136.7K, representing 72.3% of the company's reported total.
How does Legend Biotech USA Inc. rank among pharmaceutical companies? ▾
Out of 1,925 companies in the CMS Open Payments database for 2024, Legend Biotech USA Inc. ranks #1018 by total payment amount.
What is the average payment size from Legend Biotech USA Inc.? ▾
The average transaction from Legend Biotech USA Inc. was $143.53 in 2024. The company made 1,318 total transactions to 1,318 recipients.
Where does the payment data for Legend Biotech USA Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Legend Biotech USA Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.